These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 27795219)
1. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8]. Alcántara-Montiel JC; Vega-Torres BI Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219 [TBL] [Abstract][Full Text] [Related]
3. [Hyper-IgE syndromes]. He YY; Liu B; Xiao XP Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011 [TBL] [Abstract][Full Text] [Related]
4. An update on the hyper-IgE syndromes. Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525 [TBL] [Abstract][Full Text] [Related]
8. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785 [TBL] [Abstract][Full Text] [Related]
9. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review. Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791 [TBL] [Abstract][Full Text] [Related]
10. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Xie L; Hu X; Li Y; Zhang W; Chen L Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271 [TBL] [Abstract][Full Text] [Related]
11. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children. Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211 [TBL] [Abstract][Full Text] [Related]
16. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis. Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830 [TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations of hyper IgE syndromes. Freeman AF; Holland SM Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271 [TBL] [Abstract][Full Text] [Related]
18. Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports. Gomes N; Miranda J; Lopes S; Carneiro-Leão L; Torres Costa J; Baudrier T; Azevedo F J Investig Allergol Clin Immunol; 2020; 30(3):191-192. PubMed ID: 31820738 [No Abstract] [Full Text] [Related]
19. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570 [TBL] [Abstract][Full Text] [Related]
20. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Paulson ML; Freeman AF; Holland SM Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]